1 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Jun 02, 2025
2 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! May 27, 2025
3 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For May 05, 2025
5 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 17, 2025
6 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Apr 10, 2025
Read More Disease Sudden Red Spots On Your Skin? Beware Of The "Undead Cancer", Be Alert To These Signs May 30, 2025
Read More Medical Cabozantinib In Combination With Atelizumab Works Well For Advanced Head And Neck Cancer Jun 05, 2025